May 17, 2022
Net Insurance
Solid FY 21 and Q1 22 results; waiting for the new plan
Sponsored Research
May 18, 2022
ABP Nocivelli
Visibility on resilient EBITDA at undemanding multiples
April 29, 2022
Shedir Pharma
FY 21 results in line with expectations and positive outlook on 2022
April 12, 2022
Osai
Robust order intake ensures good visibility on 2022 growth
November 29, 2021
Shedir Pharma
H1 21 sales and profitability in line with H1 20
October 11, 2021
DeA Capital
H1 21: cash and the fee-based business are still the main drivers